NCT06680752
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06680752
Title Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors ARCE Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.